Spero Therapeutics (SPRO) Assets Average (2017 - 2025)
Historic Assets Average for Spero Therapeutics (SPRO) over the last 9 years, with Q3 2025 value amounting to $58.1 million.
- Spero Therapeutics' Assets Average fell 5920.29% to $58.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.1 million, marking a year-over-year decrease of 5920.29%. This contributed to the annual value of $146.5 million for FY2024, which is 464.17% down from last year.
- Spero Therapeutics' Assets Average amounted to $58.1 million in Q3 2025, which was down 5920.29% from $69.9 million recorded in Q2 2025.
- Over the past 5 years, Spero Therapeutics' Assets Average peaked at $175.0 million during Q1 2024, and registered a low of $58.1 million during Q3 2025.
- Moreover, its 5-year median value for Assets Average was $122.9 million (2024), whereas its average is $120.3 million.
- Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 6079.59% in 2023, then crashed by 5920.29% in 2025.
- Quarter analysis of 5 years shows Spero Therapeutics' Assets Average stood at $157.9 million in 2021, then crashed by 40.06% to $94.6 million in 2022, then surged by 52.94% to $144.7 million in 2023, then fell by 15.13% to $122.9 million in 2024, then tumbled by 52.67% to $58.1 million in 2025.
- Its last three reported values are $58.1 million in Q3 2025, $69.9 million for Q2 2025, and $94.1 million during Q1 2025.